JAGX ▲ +4.3% - Jaguar Health, Inc. $JAGX - Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Jaguar Health shares rose 4.3% after the company announced an additional infant patient will receive its drug crofelemer through a compassionate use program for intestinal failure treatment. The expanded patient access demonstrates continued clinical demand for the therapy and suggests progress in addressing a serious pediatric condition. 04-SEP-2026 08:30 AM ET